-
Consumer Product Enforcement Summary Report - Cyclical Enforcement Project...
The purpose of this standards project was to sample USB wall chargers and test them to the performance criteria of a consensus-based safety standard in order to verify... -
Novel Food Information - Insect Resistant Cotton COT67B
Health Canada has notified Syngenta Seeds Canada Inc. that it has no objection to the sale of food derived fromInsect Resistant Cotton COT67B. The Department conducted a... -
Summary Safety Review - Intraocular lenses - Assessing the potential risk of...
As part of Health Canada's ongoing monitoring of glistening development in IOLs, Health Canada reviewed the available safety information related to this issue. Health Canada has... -
List of Permitted Sequestering Agents (Lists of Permitted Food Additives)
This List of Permitted Sequestering Agents sets out authorized food additives that are used to control the availability of cations. -
Guidance for Evaluating Human Health Impacts in Environmental Assessments:...
This document provides generic guidance on predicting health risks associated with contamination of country foods, such as fruit, fish, seafood and game in federal environmental... -
Guidance Document on the Distribution of Drugs as Samples - Summary
The purpose of this document is to assist stakeholders with the interpretation of legislation and regulatory requirements about distributing samples of prescription drugs, non-... -
Novel Food Information - Coffeeberry Whole Coffee Fruit Derivatives
Health Canada has notified VDF FutureCeuticals, Inc., that it has no objection to the sale of Coffeeberry® whole coffee fruit derivatives as ingredients for use in foods and... -
Canadian Health and Safety Campaign: Testing of Creative Components
A series of health-related data sets from various quantitative public opinion research studies. -
Climate Change and Health: Adaptation Bulletin #3
Adaptation Bulletin - #3/ Understanding Community Resilience to Extreme Heat Through Table-top Exercises -
Compliance and Enforcement Policy (POL-0001)
As part of its regulatory responsibilities, Health Canada monitors compliance, undertakes enforcement activities and works towards preventing non-compliance. This policy... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document – Barium
This guideline technical document reviews and assesses all identified health risks associated with barium in drinking water. It assesses new studies and approaches and takes... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
The maximum acceptable concentration (MAC) for chlorite in drinking water is 1 mg/L. The MAC for chlorate in drinking water is 1 mg/L. A guideline for chlorine dioxide is not... -
Regulatory Directive DIR2017-03, Registration of Pesticides for Emergency...
The purpose of this document is to inform registrants, user groups, government agencies and other interested stakeholders about the procedure for registering pesticides or... -
Mandatory reporting requirements for hospitals
Reporting requirements of serious adverse drug reactions and medical device incidents for hospitals. -
Guidelines for Canadian drinking water quality – Malathion: Analytical and...
Standardized methods available for the analysis of malathion in source and drinking water and their respective MDLs are summarized in Table 4. MDLs are dependent on the sample... -
Label Process Series LPS2011-01, Pesticide Labelling Framework
The purpose of this document is to provide guidance to industry and other interested parties on the development of pest control product labels for the Canadian marketplace. It... -
Prohibitions related to Purchasing Reproductive Material and Purchasing or...
The AHR Act forbids the buying and selling of in vitro embryos in Canada. -
Community Pharmacy Inspection Program discovers drug diversion in Hamilton pharmacy
Health Canada helps protect Canadians by minimizing the diversion and problematic use of controlled substances such as such as oxycodone, morphine, fentanyl and benzodiazepines.... -
Special Review Decision SRD2020-03, Special Review Decision: Metaldehyde
This document presents the final regulatory decision for the special review of metaldehyde. To comply with this decision, the required label amendments (Appendix II) must be... -
Expert Advisory Group on Marketing of Opioids
The Expert Advisory Group on Marketing of Opioids was established to provide Health Canada with input and advice regarding the evidence on the extent, impact, and value of the...